An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation

Completed · Phase 3

Conditions studied: Chronic Constipation, Irritable Bowel Syndrome With Constipation

In brief

The objective of this study is to assess the long-term safety of linaclotide administered to patients with chronic constipation (CC) or irritable bowel syndrome with constipation (IBS-C).

Key facts

Study ID
NCT00765999
Run by
Forest Laboratories
People needed
1559
Starts
2008-10-31
Expected to finish
2012-01-31
Last updated by the study team
2019-02-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.